Jakavi is a medicine containing the active ingredient(s) ruxolitinib. On this page you will find out more about Jakavi, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: ruxolitinib
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Jakavi 15 mg tablet, 56
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
JAKAVI is indicated for the treatment of disease-related splenomegaly or symptoms in patients with primary myelofibrosis, post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis. JAKAVI is indicated for the treatment of adult patients with polycythemia vera who are resistant to or intolerant of hydroxyurea.
Table of characteristics
Ovaloid curved white to almost white tablet with NVR debossed on one side and L15 debossed on the other side
Images are the copyright of the Pharmacy Guild of Australia
|Route of administration||Oral|
112: Prescription Only Medicine, or Prescription Animal Remedy
14: Prescription Only Medicine, or Prescription Animal Remedy
168: Prescription Only Medicine, or Prescription Animal Remedy
224: Prescription Only Medicine, or Prescription Animal Remedy
28: Prescription Only Medicine, or Prescription Animal Remedy
56: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 30 degrees Celsius|
|Storage conditions||Protect from Moisture|
|Life time||24 Months|
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 April 2018
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.